• Home
  •  / Zimmer Biomet

Zimmer Biomet

  • Revenue$7 BFY, 2020
  • Market Capitalization$25 B2022-05-25

OverviewSuggest Edit

Zimmer Biomet is a musculoskeletal healthcare company. It designs, manufactures, and markets orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, office-based technologies, spine, craniomaxillofacial and thoracic products, dental implants, and related surgical products. Zimmer Biomet's products and solutions help treat patients suffering from disorders and injuries of bones, joints, and supporting soft tissues.

TypePublic
Founded1927
HQWarsaw, IN, USMap
Websitezimmerbiomet.com
Employee Ratings3.6
Overall CultureBMore
View Jobs (539)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2020)20,000
Job Openings539
Revenue (FY, 2020)$7 B(-11%)
Share Price (May 2022)$119.2
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Zimmer Biomet

Bryan C. Hanson

Bryan C. Hanson

Chairman, President and Chief Executive Officer
Blaine Dart

Blaine Dart

Vice President, Compliance Officer, US and Canada
Chad Phipps

Chad Phipps

Senior Vice President, General Counsel, Secretary
Rachel Ellingson

Rachel Ellingson

Senior Vice President and Chief Strategy Officer
Ellie Humphrey

Ellie Humphrey

Senior Vice President, Chief Transformation Officer
Sang Yi

Sang Yi

Group President, Asia Pacific
Show more

Zimmer Biomet Office Locations

Zimmer Biomet has offices in Warsaw, Dover, Miami, Ashford and in 43 other locations
Warsaw, IN, US (HQ)
345 E Main St
Dover, OH, US
200 W Ohio Ave
Miami, FL, US
6303 Blue Lagoon Dr
Warsaw, IN, US
1800 W Center St
Ashford, AU
23 Alexander Ave
Canterbury, AU
313 Canterbury Rd
Show all (54)

Zimmer Biomet Financials and Metrics

Zimmer Biomet Revenue

Embed Graph
View revenue for all periods
Zimmer Biomet's revenue was reported to be $7.02 b in FY, 2020 which is a 12% decrease from the previous period.
USD

Revenue (Q3, 2021)

1.9b

Gross profit (Q3, 2021)

1.3b

Gross profit margin (Q3, 2021), %

69.8%

Net income (Q3, 2021)

145.8m

EBIT (Q3, 2021)

214.9m

Market capitalization (25-May-2022)

25.0b

Closing stock price (25-May-2022)

119.2

Cash (30-Sept-2021)

919.6m

EV

31.6b
Zimmer Biomet's current market capitalization is $25 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

7.9b8.0b7.0b

Revenue growth, %

1%1%(12%)

Cost of goods sold

2.3b2.3b2.1b

Gross profit

5.7b5.7b4.9b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

2.0b2.0b1.9b1.8b1.2b1.9b1.8b2.0b1.9b

Cost of goods sold

553.4m581.3m535.7m487.1m424.5m569.4m516.4m581.6m581.5m

Gross profit

1.4b1.4b1.4b1.3b801.6m1.4b1.3b1.4b1.3b

Gross profit Margin, %

72%71%72%73%65%70%72%71%70%
show all
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

542.8m617.9m802.1m

Accounts Receivable

1.3b1.4b1.5b

Prepaid Expenses

352.3m357.1m377.8m

Inventories

2.3b2.4b2.5b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

586.8m403.1m512.5m2.4b713.4m967.3m724.3m1.0b919.6m

Accounts Receivable

1.2b1.2b1.2b1.0b1.1b1.3b1.4b1.4b1.4b

Prepaid Expenses

376.9m396.5m375.9m435.0m432.4m352.4m383.9m361.0m168.7m

Inventories

2.3b2.3b2.4b2.5b2.5b2.5b2.5b2.5b2.5b
show all
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(379.3m)1.1b(137.4m)

Depreciation and Amortization

1.0b1.0b1.0b

Inventories

(199.5m)(125.2m)(40.8m)

Accounts Payable

155.9m(42.0m)(95.1m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

246.2m378.1m810.1m(509.1m)(717.3m)(471.2m)197.7m340.2m486.0m

Depreciation and Amortization

247.7m500.7m752.2m253.0m508.7m767.3m268.7m535.2m800.3m

Inventories

(50.7m)(83.0m)(106.0m)(96.0m)(122.6m)(108.6m)(86.1m)94.4m(94.6m)

Accounts Payable

(231.4m)(269.8m)(162.7m)(95.8m)(233.9m)(131.4m)(161.2m)(56.3m)(7.1m)
show all
USDFY, 2018

Revenue/Employee

417.5k

Debt/Equity

0.8 x

Debt/Assets

0.4 x

Financial Leverage

2.1 x
Show all financial metrics

Zimmer Biomet Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Patents and Patent Applications

4.5 k7 k8 k8 k8.5 k9 k

Countries (Facilities)

4040404040

Manufacturing Facilities

30

Facilities

340

Zimmer Biomet Acquisitions / Subsidiaries

Company NameDateDeal Size
A&E Medical CorporationDecember 01, 2020$244
RespondwellOctober 27, 2016
Clinical GraphicsSeptember 15, 2016
CD DiagnosticsAugust 16, 2016
Medtech SASJuly 18, 2016€164 m
Compression Therapy ProductsJune 13, 2016
LDR HoldingJune 07, 2016$1 b
Cayenne MedicalApril 25, 2016
Ortho TransmissionMarch 01, 2016
EtexOctober 01, 2014
Show more

Zimmer Biomet Revenue Breakdown

Embed Graph

Zimmer Biomet revenue breakdown by business segment: 24.9% from Hips, 14.9% from Dental, 7.4% from Other , 18.8% from S.E.T and 34.0% from Knees

Zimmer Biomet revenue breakdown by geographic segment: 62.2% from Americas, 20.0% from EMEA and 17.8% from Asia Pacific

Zimmer Biomet Cybersecurity Score

Cybersecurity ratingPremium dataset

B

81/100

Learn more about our premium products
SecurityScorecard logo

Zimmer Biomet Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

Learn more about our premium products
CSRHub logo

Zimmer Biomet Online and Social Media Presence

Zimmer Biomet's Trends

Embed Graph

Zimmer Biomet Company Culture

  • Overall Culture

    B

    70/100

  • CEO Rating

    B

    71/100

  • Compensation

    B

    72/100

  • Diversity

    C+

    68/100

Learn more on Comparably

Zimmer Biomet News and Updates

May 17, 2022

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2022

WARSAW, Ind., May 17, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2022. The cash...
May 16, 2022

Zimmer Biomet Announces Appointment of New Chief Accounting Officer

Paul Stellato Joins Zimmer Biomet as Vice President, Controller and Chief Accounting Officer WARSAW, Ind., May 16, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Paul Stellato as Vice President,...
May 10, 2022

Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni™ Suite Intelligent Operating Room

Artificial Intelligence-Based Object Recognition Automates Manual Tasks and Data Collection to Optimize Operating Room Workflow Efficiency WARSAW, Ind., May 10, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today introduced the...
May 03, 2022

Zimmer Biomet Announces First Quarter 2022 Financial Results

First quarter net sales from continuing operations of $1.663 billion increased 3.9% and 6.8% on a constant currency1 basis First quarter diluted earnings per share from continuing operations were $0.35; adjusted1 diluted earnings per share from continuing operations were $1.61 Company...
April 27, 2022

Zimmer Biomet to Present at the BofA Securities Healthcare Conference

WARSAW, Ind., April 27, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the BofA Securities...
April 25, 2022

Global Hip Replacement Implants Market (2022 to 2027) - Featuring Zimmer Biomet Holdings, Smith & Nephew and Stryker Among Others

DUBLIN, April 25, 2022 /PRNewswire/ -- The "Global Hip Replacement Implants Market - Analysis By Type, Surgical Approach, Fixation Approach, By Region, By Country (2022 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2022-2027)" report has been added to...
Show more

 Zimmer Biomet Frequently Asked Questions

  • When was Zimmer Biomet founded?

    Zimmer Biomet was founded in 1927.

  • Who are Zimmer Biomet key executives?

    Zimmer Biomet's key executives are Bryan C. Hanson, Blaine Dart and Chad Phipps.

  • How many employees does Zimmer Biomet have?

    Zimmer Biomet has 20,000 employees.

  • What is Zimmer Biomet revenue?

    Latest Zimmer Biomet annual revenue is $7 b.

  • What is Zimmer Biomet revenue per employee?

    Latest Zimmer Biomet revenue per employee is $351.2 k.

  • Who are Zimmer Biomet competitors?

    Competitors of Zimmer Biomet include DePuy Synthes, Smith & Nephew and Wright Medical.

  • Where is Zimmer Biomet headquarters?

    Zimmer Biomet headquarters is located at 345 E Main St, Warsaw.

  • Where are Zimmer Biomet offices?

    Zimmer Biomet has offices in Warsaw, Dover, Miami, Ashford and in 43 other locations.

  • How many offices does Zimmer Biomet have?

    Zimmer Biomet has 54 offices.